You are viewing the site in preview mode

Skip to main content

Articles

Page 2 of 19

  1. Bile acid metabolism plays a crucial role in maintaining the delicate balance between coagulation and anticoagulation processes. However, there is a paucity of research exploring the relationship between serum...

    Authors: Bolin Li, Xinxin Feng, Xinping Kang, Yi Zhao, Miaomiao Cao, Bao Xu, Hui Liu, Shuyi Deng, Yue Wu and Tao Zheng
    Citation: Thrombosis Journal 2025 23:1
  2. Disseminated intravascular coagulation (DIC) is a severe complication in septic patients. The Japanese Ministry of Health and Welfare (JMHW)-DIC criteria, the first DIC criteria, were established in 1983, and ...

    Authors: Tadashi Matsuoka, Kazuma Yamakawa, Yutaka Umemura, Koichiro Homma, Toshiaki Iba and Junichi Sasaki
    Citation: Thrombosis Journal 2024 22:112
  3. Ischaemic stroke (IS) has become a major health problem globally as it is one of the leading causes of long-term disability and death. This study aimed to evaluate the association between red cell distribution...

    Authors: Liqiang Chen, Jianchao Li, Shuang Wang, Lizhen Zhao and Shuai Hu
    Citation: Thrombosis Journal 2024 22:111
  4. Previous studies using genetically modified mouse models and inhibitors have shown that protein disulfide isomerase (PDI) family plays a significant role in arterial thrombosis. However, their role in venous t...

    Authors: Chao He, Aizhen Yang, Yuxin Zhang, Zhenzhen Zhao, Yi Lu, Jingyu Zhang and Yi Wu
    Citation: Thrombosis Journal 2024 22:110
  5. Lupus anticoagulant (LA) is an in vitro phenomenon with prolongation of a phospholipid-dependent coagulation test which is not due to an inhibitor specific to a coagulation factor. Occasionally, addition of no...

    Authors: Ting Hon Stanford Li, Pui Lun Yip, Hui Yiu Chan, Ho Kin Stephen Chan and Wai Shan Wong
    Citation: Thrombosis Journal 2024 22:109
  6. The gut microbiota of venous thromboembolism (VTE) patients exhibited significant alterations. However, the causal relationship between gut microbiota and VTE has not been fully understood. This study aimed to...

    Authors: Linfeng Xi, Hongyi Wang, Jie Du, Anqi Liu, Jianping Wang, Yifei Ni, Shuai Zhang, Wanmu Xie, Min Liu and Chen Wang
    Citation: Thrombosis Journal 2024 22:106
  7. Many studies have indicated that hyperuricemia is positively correlated with secondary deep venous thrombosis (DVT); however, the risk factors for idiopathic DVT based on gender differences, such as serum uric...

    Authors: Xiaoyu Cheng, Fei Yan, Xue Xiaomei, Qin He, Tian Liu, Lidan Ma and Ming Dong
    Citation: Thrombosis Journal 2024 22:105
  8. This critique evaluates a retrospective observational study on the impact of extracorporeal membrane oxygenation (ECMO) treatments on acquired von Willebrand syndrome (AVWS) in patients with out-of-hospital ca...

    Authors: Zaib Un Nisa Mughal and Abdul Malik
    Citation: Thrombosis Journal 2024 22:104

    The original article was published in Thrombosis Journal 2024 22:46

  9. The relationship between venous thromboembolism and both insulin resistance and metabolic syndrome is still a matter of debate. The objective of this work was to investigate the possible association between ce...

    Authors: Mohammed I Oraby, Manar M Haddad, Mona Nasser and Mona Hussein
    Citation: Thrombosis Journal 2024 22:103
  10. The high incidence of deep vein thrombosis (DVT) in evacuees has been recognized since the 2004 Niigata-Chuetsu Earthquake in Japan. We hypothesized that the number and location of communicating branches of th...

    Authors: Yoko Tabira, Joe Iwanaga, Shinichi Tanaka, Keishiro Kikuchi, Keigo Shimizu, Tatsuya Harano, Aya Han, Yuto Haikata, Eiko Inoue, Tsuyoshi Saga, R. Shane Tubbs and Koichi Watanabe
    Citation: Thrombosis Journal 2024 22:102
  11. Inflammatory dermatologic diseases have long been viewed as a “skin limited” disease process. Current literature on inflammatory dermatologic diseases investigates their relationship and influence on thromboem...

    Authors: Divya Sharma, Sierra Thomas, Trace B. Moody, Mitchell Taylor, Bianca Ituarte, Corey J. Georgeson, Christopher D. Barrett and Erin X. Wei
    Citation: Thrombosis Journal 2024 22:101
  12. Patients with traumatic pelvic fracture (TPF) are at high risk for developing deep vein thrombosis (DVT). However, there is still no unified standard on how to distinguish high-risk groups for DVT in patients ...

    Authors: Dongcheng Shi, Yongxia Li, Xiaoguang Zhu, Meifang Li and Jiamei Jiang
    Citation: Thrombosis Journal 2024 22:100
  13. COVID-19 may induce a state of hypercoagulability, particularly in critically ill patients, for reasons that remain unknown. Numerous studies have identified the presence of antiphospholipid antibodies in pati...

    Authors: Zong-fang Ren, Ri-cheng Xiong, Ling-ling Wang, Zhi-huang Chen, Rui Chen and Zhi-feng Liu
    Citation: Thrombosis Journal 2024 22:99
  14. Authors: Hans Johan Niklas Lorentsson, Christina R. Clausen, Daniel Faurholt-Jepsen, Katrine Bagge Hansen, Sidse Graff Jensen, Rikke Krogh-Madsen, Per G. Hagelqvist, Pär I. Johansson, Tina Vilsbøll, Filip K. Knop and Pernille Ravn
    Citation: Thrombosis Journal 2024 22:98

    The original article was published in Thrombosis Journal 2024 22:54

  15. We congratulate Hägg et al. on their study investigating cancer incidence and mortality following first-ever venous thromboembolism (VTE), which provides valuable insights into VTE as a potential marker for un...

    Authors: Minh-Hoang Tran and Kim-Huong Truong-Nguyen
    Citation: Thrombosis Journal 2024 22:96

    The original article was published in Thrombosis Journal 2024 22:77

    The Matters Arising to this article has been published in Thrombosis Journal 2024 22:97

  16. The D-dimer to fibrinogen ratio (DFR) represents an emerging and significant clinical biomarker. However, its correlation with cerebral venous thrombosis (CVT) remains underexplored. This retrospective cohort ...

    Authors: Duo Lan, Mengqi Wang, Xiaoming Zhang, Xiangqian Huang, Naiqi Liu, Xiangyu Ren, Kun Fang, Da Zhou and Ran Meng
    Citation: Thrombosis Journal 2024 22:95

    The Correspondence to this article has been published in Thrombosis Journal 2025 23:46

  17. Atypical hemolytic uremic syndrome (aHUS) is a rare disease with poor outcomes when untreated, in which ravulizumab or eculizumab are the standard of care where available. It has been proposed to regularly mon...

    Authors: Masanori Matsumoto, Akihiko Shimono, Jun Yokosawa, Keiichiro Hirose, Edward Wang and Shoichi Maruyama
    Citation: Thrombosis Journal 2024 22:93
  18. Bleeding complications following intramuscular (IM) injections are generally considered rare with reported incidence of 0.06%. However, evidence on safety of IM injections among anticoagulated hospitalized pat...

    Authors: Marina Davidov, Ronen Loebstein, Hagith Yonath and Itai Gueta
    Citation: Thrombosis Journal 2024 22:92
  19. Hypothermia and acidosis individually inhibit haemostasis. We designed this study with the aim to investigate whether rivaroxaban combined with hypothermia or acidosis exhibit synergistic inhibitory effects on...

    Authors: Lotta Sunnersjö, Isak Ymén, Ulf Schött, Andreas Hillarp, Johan Undén and Thomas Kander
    Citation: Thrombosis Journal 2024 22:91
  20. Recent years have seen ticagrelor, a potent P2Y12 inhibitor, emerge as a significant advancement in the peri-thrombolytic management of patients with ST-segment elevation myocardial infarction (STEMI), offerin...

    Authors: Junyan Zhang, Lingya Li, Zhongxiu Chen and Yong He
    Citation: Thrombosis Journal 2024 22:90
  21. Bleeding events in patients receiving direct oral anticoagulation (DOAC) can be life-threatening even at therapeutic DOAC plasma concentrations, as anticoagulation impairs hemostasis and should therefore be id...

    Authors: Lars Heubner, Oliver Grottke, Oliver Vicent, Peter Markus Spieth and Jan Beyer-Westendorf
    Citation: Thrombosis Journal 2024 22:89
  22. Essential thrombocythemia (ET) is a myeloproliferative malignancy caused by the excessive proliferation of megakaryocytes in the bone marrow, resulting in the overproduction of peripheral platelets. ET can lea...

    Authors: Shuyue Xiao, Yan Ding, Anding Xu and Menglong Chen
    Citation: Thrombosis Journal 2024 22:88
  23. The association between uric acid and pulmonary embolism(PE) remains controversial, and there has been limited investigation into how uric acid influences pulmonary embolism across different age groups. Our st...

    Authors: Bin Yuan, Lingyue Song, Weiqing Su, Xianbing Zeng, Jinqiang Su, Jie Sun, Jun Wu, Kaili Fu, Zhihai Huang, Qiaoyun Chen, Dingyu Guo, Xishi Sun and Lingpin Pang
    Citation: Thrombosis Journal 2024 22:87
  24. Carotid artery stenting (CAS) is a key treatment option for moderate to severe carotid artery stenosis. Carotid stent thrombosis (CST), a rare complication of CAS, has gained significant attention because of i...

    Authors: Tianzhu Liu, Li Chen, Shiyu Deng, Jie He, Dekang Li and Yunbo Chen
    Citation: Thrombosis Journal 2024 22:86
  25. Homozygous familial hypercholesterolemia (HoFH), is a rare genetic disorder characterized by dual mutations in the low-density lipoprotein receptor (LDLR) gene, leading to dysfunctional or absent LDLRs, often ...

    Authors: Mingjing Guan, Hao Wang, Fang Wang, Shichu Liang, Li Ling, Bo Wang and Ling Zhang
    Citation: Thrombosis Journal 2024 22:85
  26. Sepsis is a life-threatening condition that affects 49 million people annually. Managing sepsis-associated coagulopathy poses a significant challenge due to its high mortality rates in intensive care. Recent r...

    Authors: Takaaki Totoki, Hiroyuki Koami, Yuto Makino, Takeshi Wada, Takashi Ito, Kazuma Yamakawa and Toshiaki Iba
    Citation: Thrombosis Journal 2024 22:84
  27. Cardiac embolism plays a very significant role in acute ischemic strokes (AIS), constituting approximately one-third of cases. The origin of these emboli often stems from intracardiac thrombi in the left atriu...

    Authors: Zafar Ali, Abdul Wali Khan, Islam Shatla, Sayyeda Aleena Mufarrih, Rithvik Talluri and Talal Asif
    Citation: Thrombosis Journal 2024 22:83
  28. To explore the distribution of thrombin–antithrombin complex (TAT), plasmin-α2-antiplasmin inhibitor complex (PIC), thrombomodulin (TM), and tissue plasminogen activator-inhibitor complex (t-PAIC) in healthy o...

    Authors: Lei Zhang, Yiming Chen, Rong Hu, Hua Chen, Xu Peng and Hui Yuan
    Citation: Thrombosis Journal 2024 22:82
  29. Venous thromboembolism (VTE) in pregnancy is a major cause of maternal morbidity and mortality, and the use of preventive low-molecular-weight heparin (LMWH) can be challenging. Clinical guidelines recommend e...

    Authors: Montserrat León‑García, Brittany Humphries, Feng Xie, Derek L. Gravholt, Elizabeth Golembiewski, Mark H. Eckman, Shannon M. Bates, Ian Hargraves, Irene Pelayo, Sandra Redondo López, Juan Antonio Millón Caño, Milagros A. Suito Alcántara, Rohan D’Souza, Nadine Shehata, Susan M. Jack, Gordon Guyatt…
    Citation: Thrombosis Journal 2024 22:81
  30. Coronavirus-19 disease (COVID-19) frequently causes coagulation disturbances. Data remains limited on the effects of microRNAs (miRNAs) on coagulation during COVID-19 infection. We aimed to analyze the compreh...

    Authors: Tuukka A. Helin, Marja Lemponen, Katariina Immonen, Päivi Lakkisto and Lotta Joutsi-Korhonen
    Citation: Thrombosis Journal 2024 22:80
  31. Echinocandins belong to the fourth generation of antifungals, and there are no systematic studies on their risk in coagulation dysfunction; this study will predict the risk of coagulation dysfunction of echino...

    Authors: Qian Cheng, Ye Wu, Zeyu Yao, Mengling Ouyang, Shupeng Zou, Xuan Shi, Yazheng Zhao and Minghui Sun
    Citation: Thrombosis Journal 2024 22:78
  32. Venous thromboembolism (VTE) has a high mortality rate and can be the first manifestation of cancer. We investigated the incidence of cancer after first-ever VTE and the association between VTE and all-cause m...

    Authors: Lovisa Hägg, Felicia Ehrs, Marcus Lind and Magdalena Johansson
    Citation: Thrombosis Journal 2024 22:77

    The Matters Arising to this article has been published in Thrombosis Journal 2024 22:96

  33. To identify the key risk factors for venous thromboembolism (VTE) in urological inpatients based on the Caprini scale using an interpretable machine learning method.

    Authors: Chao Liu, Wei-Ying Yang, Fengmin Cheng, Ching-Wen Chien, Yen-Ching Chuang and Yanjun Jin
    Citation: Thrombosis Journal 2024 22:76
  34. Atresia of the infrarenal inferior vena cava (IVC) is associated with thrombophilia and antithrombin (AT) deficiency (ATD) due to homozygosity for the so-called Budapest 3 variant, c.391C > T, in the gene, SERPIN...

    Authors: Nina Iversen, Carola Elisabeth Henriksson, Marit Sletten, Marie Skogstad Le, Beate Rikken Lindberg, Rune Andersen and Benedicte Paus
    Citation: Thrombosis Journal 2024 22:75
  35. Proper control of the lineage bias of megakaryocytic and erythroid progenitor cells (MEPs) is of significant importance, the disorder of which will lead to abnormalities in the number and function of platelets...

    Authors: Xin Yuan, Pengcong Liu, Lei Xu, Liqing Liang, Qian Dong, Tao Fan, Wen Yue, Mingyi Qu, Xuetao Pei and Xiaoyan Xie
    Citation: Thrombosis Journal 2024 22:74
  36. Exposure to a high-altitude environment is a risk factor for cerebral venous thrombosis (CVT) probably due to hypercoagulability. The study aims to explore the unique characteristics of CVT patients in high-al...

    Authors: Yuhui Sha, Junyi Zhang, Yang Ci, Cidan zhuoga, Yuhua Zhao, Lixin Zhou and Jun Ni
    Citation: Thrombosis Journal 2024 22:73
  37. A recent Phase 2/3 study in Japanese patients showed that caplacizumab was effective in treating immune-mediated thrombotic thrombocytopenic purpura (iTTP), with a low rate of iTTP recurrence. ADAMTS13 activit...

    Authors: Kazunori Imada, Yoshitaka Miyakawa, Satoshi Ichikawa, Hitoji Uchiyama, Yasunori Ueda, Yasuhiro Hashimoto, Masashi Nishimi, Masako Tsukamoto, Sayaka Tahara and Masanori Matsumoto
    Citation: Thrombosis Journal 2024 22:72
  38. Inherited antithrombin, protein C, and protein S deficiency increase the risk of venous thromboembolism. The presence of defects can be identified by clinical laboratory assays. In most Chinese clinical labora...

    Authors: Houmei Feng, Danyu Song, Qiang Xu, Xiaohui Cai, Jianru Liu, Yang Zhang and Zhou Zhou
    Citation: Thrombosis Journal 2024 22:70
  39. Thromboangiitis obliterans (TAO) remains clinical challenging due to its rarity and underwhelming management outcomes. This study aimed to describe a novel TAO rabbit model that demonstrates a closer resemblan...

    Authors: Jia-Long Li, Kristine J. S. Kwan, Xue-Guang Lin, Jie Wang, Bo Chen, Yi-Jie Lu, Bo Wang, Shi-Shuai Xie, Jiong Zhou, Bo Yu, Ying Deng, Shuai Jiang and Jing-Dong Tang
    Citation: Thrombosis Journal 2024 22:69
  40. This study aims to investigate the potential role of Caprini risk assessment model (RAM) in predicting the risk of venous thromboembolism (VTE) in patients undergoing total hip or knee arthroplasty (THA/TKA). ...

    Authors: Zhencan Lin, Hao Sun, Meiyi Chen, Deng Li, Zhiqing Cai, Yimin Wang, Jie Xu and Ruofan Ma
    Citation: Thrombosis Journal 2024 22:68
  41. Thrombocytopenia frequently occurs in patients with sepsis. Disseminated intravascular coagulation (DIC) may be a possible cause of thrombocytopenia owing to its high prevalence and association with poor outco...

    Authors: Kasumi Satoh, Takeshi Wada, Akihito Tampo, Gaku Takahashi, Kota Hoshino, Hironori Matsumoto, Takayuki Taira, Satoshi Kazuma, Takamitsu Masuda, Takashi Tagami and Hiroyasu Ishikura
    Citation: Thrombosis Journal 2024 22:67
  42. This research is one of the pioneering randomized clinical trials (RCTs) aimed at assessing the effectiveness and safety of rivaroxaban in treating left ventricular thrombus (LVT) in patients who have experien...

    Authors: Pejman Mansouri, Zahra Azamian Jazi, Mohammad Hadi Mansouri, Hooman Dehghan, Reihaneh Zavar, Seyedeh Melika Hashemi, Fereshteh Sattar, Masoumeh Sadeghi, Afshin Amirpour and Morteza Abdar
    Citation: Thrombosis Journal 2024 22:66
  43. This study aimed to describe the status of antithrombotic therapy at discharge and prognosis in patients with atrial fibrillation (AF) and chronic coronary syndrome (CCS) who underwent percutaneous coronary in...

    Authors: Yimeng Wang, Yanmin Yang, Lulu Wang, Han Zhang, Jiang-shan Tan and Yuyuan Shu
    Citation: Thrombosis Journal 2024 22:65

Official journal of

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.1
    Source Normalized Impact per Paper (SNIP): 0.653
    SCImago Journal Rank (SJR): 0.572

    Speed 2024
    Submission to first editorial decision (median days): 13
    Submission to acceptance (median days): 108

    Usage 2024
    Downloads: 622,602
    Altmetric mentions: 627